SEC Form 4 · accession 0000874015-16-000120
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Frank Bennett
Officer — SVP, Antisense Research
Period of report
Jul 1, 2016
Accepted (ET)
Jul 1, 2016 · 8:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2016 | J | 213 | $20.757 | A | 10,803 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting 213 shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2016. These 213 shares may not be sold until January 2, 2017.